Eurazeo (FR:RF) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Eurazeo, in partnership with Kurma Partners, has invested in PanTera through a €93 million financing round aimed at establishing large-scale production of Actinium-225, a promising cancer-fighting radioisotope. This investment marks Eurazeo’s second Growth Equity investment and reinforces its commitment to healthcare innovation in Europe. PanTera plans to significantly increase production to support 100,000 patients annually by 2029, contributing to European medical sovereignty and access to healthcare.
For further insights into FR:RF stock, check out TipRanks’ Stock Analysis page.
